KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Acquisitions (2016 - 2019)

Bausch Health Companies (BHC) has disclosed Acquisitions for 10 consecutive years, with $180.0 million as the latest value for Q1 2019.

  • Quarterly Acquisitions rose 3700.0% to $180.0 million in Q1 2019 from the year-ago period, while the trailing twelve-month figure was $180.0 million through Dec 2019, up 3700.0% year-over-year, with the annual reading at $1.9 billion for FY2023, 4100.0% up from the prior year.
  • Acquisitions hit $180.0 million in Q1 2019 for Bausch Health Companies, up from -$5.0 million in the prior quarter.
  • In the past five years, Acquisitions ranged from a high of $13.1 billion in Q2 2015 to a low of -$5.0 million in Q1 2018.
  • Historically, Acquisitions has averaged $1.7 billion across 4 years, with a median of $115.8 million in 2015.
  • Biggest five-year swings in Acquisitions: soared 19151.32% in 2015 and later plummeted 99.87% in 2016.
  • Year by year, Acquisitions stood at $1.5 billion in 2015, then crashed by 99.66% to $5.0 million in 2016, then crashed by 200.0% to -$5.0 million in 2018, then skyrocketed by 3700.0% to $180.0 million in 2019.
  • Business Quant data shows Acquisitions for BHC at $180.0 million in Q1 2019, -$5.0 million in Q1 2018, and $5.0 million in Q3 2016.